正常人および肥満者における合成hp GRF-44の成長ホルモン分泌に関する研究
スポンサーリンク
概要
- 論文の詳細を見る
Synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) was given by i.v. bolus injection to 15 normal non-obese and 32 obese subjects who were divided into two groups according to their ages-group A : young subjects, 20-50 yrs., and group B : old subjects, more than 60 yrs. In normal subjects, hpGRF-44 had no effect on the secretion of PRL, TSH, LH, FSH, IRI and cortisol. hpGRF-44 stimulated GH secretion selectively. However, the serum GH responses were different between the young and old groups, the peak GH levels being significantly higher in the young group than in the old group (20.1±4.2 vs. 7.5±1.6 ng/ml; group A vs. B; p<0.05). At the doses of 0.5, 1.0, 2.0 and 4.0 μg/kg B.W., the serum GH responses were similar in an individual subject.<BR>In young obese subjects, the peak GH levels to hgGRF-44, 1.0 μg/kg B.W. were significantly lower than those in young normal subjects (4.3±0.6 vs. 20.1±4.2 ng/ml; obese vs. normal; p<0.01). In old subjects, the peak GH levels to hpGRF-44, 1.0 μg/kg B.W. were similarly diminished in both normal and obese subjects. However, the integrated response of GH was significantly lower in obese subjects than in normal subjects (405.9±58.7 vs. 755.9±134.2 ng·min/ml; obese vs. normal; p<0.05).<BR>In 5 young obese subjects, regular insulin (RI) injection (0.15 U/kg B.W.) and arginine drip infusion (0.5 g/kg B.W.) alone, and simultaneous injection of hpGRF-44, 1.0 μg/kg B.W. and RI, 0.15 U/kg B.W. were done. In these subjects, GH responses to RI or arginine infusion were diminished as in the case of hpGRF-44 administration, whereas the peak GH levels were higher in the RI stimulation. The combination of hpGRF-44 and RI partially restored GH response. (peak GH levels; 14.6±0.8 ng/ml).<BR>These results confirm the age difference of serum GH response to hpGRF-44 and also indicate that obese subjects show low or no response to hpGRF-44 administration. The fact that insulin hypoglycemia induced larger serum GH response than hpGRF-44 in obese subjects may suggest the existence of GH-releasing substances other than hpGRF-44.
- 一般社団法人 日本内分泌学会の論文
著者
関連論文
- 酢酸メドロキシプロゲステロン投与中に診断された副腎偶発腫の1例
- 中華人民共和国の看護識者が捉えている高齢者の生活と健康に関する意識調査
- 中華人民共和国女性看護職員の家庭における育児と教育 : 3省2自治区15病院の場合
- 中華人民共和国女性看護職員の勤務継続要因 : 3省2自治区15病院の場合
- SIADHを呈した食道小細胞性未分化癌の1例
- 原発性甲状腺機能低下症の治療経過中のTRH反応の推移に関する研究
- バセドウ病の治療経過に伴うTRHテストに関する研究
- 副腎皮質ホルモン日内変動に及ぼす給餌時間変更及び絶食の影響に関する研究
- 正常人および肥満者における合成hp GRF-44の成長ホルモン分泌に関する研究